Daxor Research and Development Expenses 2012-2011 | DXR
Daxor research and development expenses from 2012 to 2011. Research and development expenses can be defined as an expense arising from studies and product development processes.
|
Daxor Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2011 | $3 |
|
Daxor Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.057B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $25.391B | 11.38 |
| Quest Diagnostics (DGX) | United States | $21.586B | 19.23 |
| DaVita (DVA) | United States | $13.348B | 17.73 |
| Elanco Animal Health (ELAN) | United States | $12.097B | 24.71 |
| Encompass Health (EHC) | United States | $9.724B | 17.23 |
| Chemed (CHE) | United States | $5.791B | 22.16 |
| RadNet (RDNT) | United States | $4.226B | 116.83 |
| LifeStance Health (LFST) | United States | $3.483B | 149.67 |
| Option Care Health (OPCH) | United States | $3.453B | 14.28 |
| Astrana Health (ASTH) | United States | $2.182B | 26.47 |
| Addus HomeCare (ADUS) | United States | $1.759B | 16.62 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.696B | 12.77 |
| Pennant (PNTG) | United States | $1.163B | 32.47 |
| U.S Physical Therapy (USPH) | United States | $0.964B | 24.35 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.033B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |